Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,436,946 papers from all fields of science
Search
Sign In
Create Free Account
amosulalol
Known as:
5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methylbenzenesulfonamide
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (4)
Adrenergic alpha-Antagonists
Adrenergic beta-Antagonists
Antihypertensive Agents
Ethanolamines
Narrower (1)
YM 09538
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Emotional stress activates MAP kinase in the rat heart.
T. Ueyama
,
T. Aki
,
E. Senba
,
K. Hatanaka
,
K. Yoshida
Life Science
2001
Corpus ID: 35396312
1999
1999
Effect of topical amosulalol on tissue circulation in the optic nerve head.
Y. Tamaki
,
M. Araie
,
K. Muta
Journal of Ocular Pharmacology and Therapeutics
1999
Corpus ID: 25329096
The effect of topical 0.1% amosulalol on tissue circulation in the albino rabbit optic nerve head (ONH) was investigated using a…
Expand
1996
1996
[Effects of amosulalol hydrochloride on intraocular pressure and aqueous humor dynamics in the rabbit eye].
T. Taniguchi
,
T. Deguchi
,
T. Ogawa
,
Y. Kitazawa
Nippon Ganka Gakkai zasshi
1996
Corpus ID: 34518474
The effects of amosulalol, which blocks alpha 1 adrenoceptors selectively and beta receptors nonselectively almost to the same…
Expand
1993
1993
The effects of (+/-)-, (+)-, and (-)-atenolol, sotalol, and amosulalol on the rat left atria and portal vein.
S. Doggrell
Chirality
1993
Corpus ID: 21577683
The effects of (+/-)-, (+)-, and (-)-atenolol, sotalol, and amosulalol alone on the rat left atria and portal vein and on the…
Expand
Review
1990
Review
1990
Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule.
H. Stern
,
P. Haberhauer
,
P. Emmrich
,
K. Bühlmeyer
Zeitschrift für Kardiologie
1990
Corpus ID: 208311244
Combinations of beta-adrenoreceptor blocking agents and vasodilators have been widely used because of their favorable hemodynamic…
Expand
1989
1989
Beneficial effect of amosulalol and phentolamine on post‐hypoxic recovery of contractile force and energy metabolism in rabbit hearts
K. Tanonaka
,
M. Matsumoto
,
R. Minematsu
,
K. Miyake
,
R. Murai
,
S. Takeo
British Journal of Pharmacology
1989
Corpus ID: 45980988
1 The effects of phentolamine, an α‐adrenoceptor blocking agent and amosulalol, an α1 and β‐adrenoceptor antagonist on hypoxia…
Expand
1986
1986
Adrenoceptor blocking and cardiovascular effects of the optical isomers of amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent, and the corresponding desoxy derivative (YM…
K. Honda
,
C. Nakagawa
,
O. Inagaki
,
M. Shibasaki
,
T. Takenaka
,
M. Takeda
Japanese Journal of Pharmacology
1986
Corpus ID: 39314534
The pharmacological activities of the enantiomers of amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor antagonist…
Expand
1985
1985
Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
K. Honda
,
T. Takenaka
,
K. Shiono
,
A. Miyata-Osawa
,
C. Nakagawa
Japanese Journal of Pharmacology
1985
Corpus ID: 28807811
The autonomic and antihypertensive activities of amosulalol (YM-09538) were studied in conscious rats. Single oral administration…
Expand
1985
1985
Effects of amosulalol on the electrical responses of guinea‐pig vascular smooth muscle to adrenoceptor activation
M. Fujioka
,
Hikaru Suzuki
British Journal of Pharmacology
1985
Corpus ID: 44651248
1 The effects of amosulalol, a newly synthesized sulphonamide‐substituted phenylethylamine derivative, on electrical responses of…
Expand
1984
1984
Amosulalol, a combined alpha and beta adrenoceptor antagonist: Kinetics after intravenous and oral doses
M. Nakashima
,
M. Asano
,
+4 authors
T. Takenaka
Clinical pharmacology and therapy
1984
Corpus ID: 35063763
Amosulalol kinetic studies were conducted in seven subjects who received 0.16 mg/kg iv and in 18 subjects who received 12.5, 25…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE